FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Trimipramine Maleate (SURMONTIL) Capsules
Status: Currently in Shortage
»Date first posted: 08/18/2014
»Therapeutic Categories: Psychiatry

Expand all

Mikah Pharma, LLC c/o Epic Pharma, LLC (Reverified 01/22/2015)

Company Contact Information:
908-437-8232

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg 30s (NDC 45963-293-30) Product currently unavailable API manufacturer discontinued the material Shortage of active ingredient
25 mg 90s (NDC 45963-293-08) Product currently unavailable API manufacturer discontinued the material Shortage of active ingredient
25 mg 270s (NDC 45963-293-27) Product currently unavailable API manufacturer discontinued the material Shortage of active ingredient
50 mg 30s (NDC 45963-294-30) Product currently unavailable API manufacturer discontinued the material Shortage of active ingredient
50 mg 90s (NDC 45963-294-08) Product currently unavailable API manufacturer discontinued the material Shortage of active ingredient
50 mg 270s (NDC 45963-294-27) Product currently unavailable API manufacturer discontinued the material Shortage of active ingredient
100 mg 30s (NDC 45963-295-30) Product currently unavailable API manufacturer discontinued the material Shortage of active ingredient

Teva Pharmaceuticals (Reverified 08/16/2016)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
SURMONTIL(R) CAPSULES 50MG 100 (NDC 51285-0539-02) Product is currently available. Other
SURMONTIL(R) CAPSULES 25MG 100 (NDC 51285-0538-02) Product is currently available. Other
SURMONTIL(R) CAPSULES 100MG 100 (NDC 51285-0554-02 ) Product is currently available. Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.